Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

7.65
-0.1900-2.42%
Post-market: 7.650.00000.00%17:32 EDT
Volume:427.62K
Turnover:3.27M
Market Cap:2.38B
PE:35.17
High:7.81
Open:7.81
Low:7.52
Close:7.84
52wk High:13.70
52wk Low:7.35
Shares:311.60M
Float Shares:116.17M
Volume Ratio:1.06
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2175
EPS(LYR):-0.8654
ROE:--
ROA:2.83%
PB:-13.75
PE(LYR):-8.84

Loading ...

Alvotech Is Maintained at Buy by UBS

Dow Jones
·
Jul 19

UBS Adjusts Price Target on Alvotech to $14 From $16, Maintains Buy Rating

MT Newswires Live
·
Jul 18

Alvotech Names Linda Jonsdottir Finance Chief as Joel Morales Departs

Dow Jones
·
Jul 10

Alvotech Names Linda Jonsdottir as Chief Financial Officer

MT Newswires Live
·
Jul 10

BRIEF-Alvotech Appoints Linda Jónsdóttir As Chief Financial Officer

Reuters
·
Jul 10

Press Release: Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Dow Jones
·
Jul 10

Alvotech Expands Assembly and Packaging Capacity with Acquisition of Ivers-Lee Group

Reuters
·
Jul 09

Alvotech SA Announces New Stock Option Grants for Board Directors Under Revised Compensation Plan

Reuters
·
Jul 02

Alvotech and Advanz Pharma Sign European Deal for Cimzia® Biosimilar Candidate

Reuters
·
Jul 01

Alvotech SA Secures Lower Interest Rates on Senior Secured Term Loan, Reducing Payments by $8.2 Million

Reuters
·
Jun 26

Alvotech SA Held 2025 Annual and Extraordinary General Meeting

Reuters
·
Jun 26

Press Release: Main Results of 2025 Annual and Extraordinary General Meeting

Dow Jones
·
Jun 26

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Easing Middle East Tensions

MT Newswires Live
·
Jun 25

BRIEF-Alvotech SA Says Study Shows Equivalence And Safety Of AVT23 To Xolair

Reuters
·
Jun 25

Alvotech Says Proposed Xolair Biosimilar Study Meets Primary Endpoint

MT Newswires Live
·
Jun 25

Alvotech SA and Partners Announce Positive Regulatory Review for Xolair® Biosimilar AVT23, with Marketing Authorization Application Validated by UK MHRA

Reuters
·
Jun 25

European Medicines Agency Recommends Approval of Alvotech's AVT06, Proposed Biosimilar to Eylea®

Reuters
·
Jun 23

Alvotech SA Completes Successful Private Placement, Welcomes New Institutional Investors

Reuters
·
Jun 12

Nordic Shares Close Down; Alvotech Posts Biggest Loss

Dow Jones
·
Jun 12

Alvotech SA and Dr. Reddy's Laboratories Announce Partnership to Co-Develop Biosimilar to Keytruda®

Reuters
·
Jun 11